US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder
Nyxoah CEO Olivier Taelman said that the company has also trained surgeons, obtained Value Analysis Committee approvals, and achieved successful coverage from major payors.
